The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3S,6R)-3,6-Bis(p-(benzyloxy)benzyl)piperazine-2,5-dione ID: ALA4525815
PubChem CID: 155543213
Max Phase: Preclinical
Molecular Formula: C32H30N2O4
Molecular Weight: 506.60
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C1N[C@H](Cc2ccc(OCc3ccccc3)cc2)C(=O)N[C@H]1Cc1ccc(OCc2ccccc2)cc1
Standard InChI: InChI=1S/C32H30N2O4/c35-31-29(19-23-11-15-27(16-12-23)37-21-25-7-3-1-4-8-25)33-32(36)30(34-31)20-24-13-17-28(18-14-24)38-22-26-9-5-2-6-10-26/h1-18,29-30H,19-22H2,(H,33,36)(H,34,35)/t29-,30+
Standard InChI Key: ZQWZOXZKTPYDHR-RNPORBBMSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
9.7696 -9.2832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6519 -8.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6519 -8.8735 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3572 -9.2780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0624 -8.8735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0624 -8.0564 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3572 -7.6436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3572 -6.8264 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3572 -10.0952 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9430 -7.6498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2365 -8.0605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5281 -7.6509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8221 -8.0609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8241 -8.8789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5380 -9.2853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2411 -8.8729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1181 -9.2905 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4087 -8.8849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7027 -9.2966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9952 -8.8896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2897 -9.3005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2927 -10.1186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0071 -10.5240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7097 -10.1107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4779 -8.8756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1833 -9.2861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8911 -8.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8928 -8.0611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1807 -7.6517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4758 -8.0609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6005 -7.6526 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3082 -8.0613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0159 -7.6528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7224 -8.0638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4297 -7.6560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4302 -6.8380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7176 -6.4294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0132 -6.8396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 7 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
4 9 2 0
5 1 1 1
2 10 1 6
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
14 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
1 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
28 31 1 0
31 32 1 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 37 1 0
37 38 2 0
38 33 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 506.60Molecular Weight (Monoisotopic): 506.2206AlogP: 4.61#Rotatable Bonds: 10Polar Surface Area: 76.66Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.53CX Basic pKa: ┄CX LogP: 5.37CX LogD: 5.37Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: 0.13
References 1. Simon G, Bérubé C, Voyer N, Grenier D.. (2019) Anti-biofilm and anti-adherence properties of novel cyclic dipeptides against oral pathogens., 27 (12): [PMID:30528685 ] [10.1016/j.bmc.2018.11.042 ]